Directory
>
Samuel Blackman
Samuel Blackman
Research Assistant | GV (Google Ventures)
Washington, Seattle, United States
Samuel Blackman
Summary
Samuel Blackman is a mission-driven physician-scientist and biotechnology executive with over 13 years of experience in oncology clinical development, particularly focused on pediatric cancer therapeutics. As the Founder and Head of Research and Development at Day One Biopharmaceuticals, he has driven the development of innovative cancer treatments, including small molecule therapies and CAR-T cell therapies. His extensive background includes leadership roles in major pharmaceutical companies and startups, where he has successfully executed complex drug development strategies. Samuel is also deeply involved in the pediatric oncology community, serving on multiple boards and committees. In addition to his scientific pursuits, he is an accomplished storyteller, having performed at notable events like The Moth. With a strong commitment to improving outcomes for children with cancer, Samuel combines his clinical expertise with a passion for innovation in medicine.
Samuel Blackman
Work Experience
Entrepreneur in Residence at
GV (Google Ventures)
March 2025 - Present
Samuel Blackman
Education
University of Chicago, BA
January 1986 - January 1990
University of Illinois College of Medicine, MD
January 1993 - January 2001
University of Illinois Chicago, PhD
January 1993 - January 2001
Frequently Asked Questions about Samuel Blackman
What is Samuel Blackman email address?
Samuel Blackman's primary email address is ***************@dayonebio.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Samuel Blackman work for?
Samuel Blackman is a Research Assistant at GV (Google Ventures).
Where Samuel Blackman graduated from?
Samuel Blackman holds a degree in null from University of Chicago.
How can I directly contact Samuel Blackman?
To contact Samuel Blackman directly, you can use the email address ***************@dayonebio.com. Complete contact information is available upon registration with Muraena.
Who is Samuel Blackman?
Samuel Blackman is a mission-driven physician-scientist and biotechnology executive with over 13 years of experience in oncology clinical development, particularly focused on pediatric cancer therapeutics. As the Founder and Head of Research and Development at Day One Biopharmaceuticals, he has driven the development of innovative cancer treatments, including small molecule therapies and CAR-T cell therapies. His extensive background includes leadership roles in major pharmaceutical companies and startups, where he has successfully executed complex drug development strategies. Samuel is also deeply involved in the pediatric oncology community, serving on multiple boards and committees. In addition to his scientific pursuits, he is an accomplished storyteller, having performed at notable events like The Moth. With a strong commitment to improving outcomes for children with cancer, Samuel combines his clinical expertise with a passion for innovation in medicine.
Samuel`s contact details
***************@dayonebio.com
*********@notablelabs.com
***************@presagebio.com
******@litmushealth.com
Colleagues
General Partner
Intern
Scientist
Senior Director, Strategic Alliances
Software Engineer, Vehicle Navigation Systems
Senior Account Executive
Summer Analyst
Technical Analyst